Congress abstract
Partin AW, Mangold LA, Gurganus RT, Blase A, Groskopf J, Deras IL, Mathis J, Carter HB, Rittenhouse H. J Urol 2007;177(4):538 (abs. 1623)
- This abstract was presented as a poster at the 2007 Annual Meeting of the American Urological Association (AUA), 19-24 May, Anaheim, USA.
- A total of 29 PCa patients awaiting treatment or managed with watchful waiting provided a urine sample once a week for 4 weeks and the PCA3 Scores were measured.
- The variation in the individual subject’s PCA3 Score at the 4 visits was small.
- Moreover, this was independent of the applied DRE method (routine diagnostic DRE or a 3-strokes per lobe DRE) (Figure left).
- The informative rate (urine samples with sufficient mRNA to calculate the PCA3 Score) was also comparable for both DRE methods (Figure right).
